These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8912900)

  • 1. Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease.
    Chandrasekaran K; Hatanpää K; Brady DR; Rapoport SI
    Exp Neurol; 1996 Nov; 142(1):80-8. PubMed ID: 8912900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vivo imaging for evaluating synaptic integrity in Alzheimer disease].
    Rapoport SI
    Psychol Neuropsychiatr Vieil; 2005 Jun; 3(2):97-106. PubMed ID: 15929923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease.
    Brooks WM; Lynch PJ; Ingle CC; Hatton A; Emson PC; Faull RL; Starkey MP
    Brain Res; 2007 Jan; 1127(1):127-35. PubMed ID: 17109828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
    Blass JP; Gibson GE
    Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation.
    Rapoport SI
    Ann N Y Acad Sci; 1999; 893():138-53. PubMed ID: 10672235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
    Kim EJ; Cho SS; Jeong Y; Park KC; Kang SJ; Kang E; Kim SE; Lee KH; Na DL
    Brain; 2005 Aug; 128(Pt 8):1790-801. PubMed ID: 15888536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease.
    Rapoport SI
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():46-55. PubMed ID: 10654100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered glucose metabolism in microvessels from patients with Alzheimer's disease.
    Marcus DL; de Leon MJ; Goldman J; Logan J; Christman DR; Wolf AP; Fowler JS; Hunter K; Tsai J; Pearson J
    Ann Neurol; 1989 Jul; 26(1):91-4. PubMed ID: 2774504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
    Colangelo V; Schurr J; Ball MJ; Pelaez RP; Bazan NG; Lukiw WJ
    J Neurosci Res; 2002 Nov; 70(3):462-73. PubMed ID: 12391607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
    Soto A; DelRaso NJ; Schlager JJ; Chan VT
    Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease.
    Sims NR; Finegan JM; Blass JP
    Ann Neurol; 1987 May; 21(5):451-7. PubMed ID: 3109316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of energy metabolism in Alzheimer's disease is a protective response of neurons to the microenvironment.
    Sun J; Feng X; Liang D; Duan Y; Lei H
    J Alzheimers Dis; 2012; 28(2):389-402. PubMed ID: 22008267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain evolution and Alzheimer's disease.
    Rapoport SI
    Rev Neurol (Paris); 1988; 144(2):79-90. PubMed ID: 2898165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer disease.
    Rapoport SI; Hatanpää K; Brady DR; Chandrasekaran K
    Neurodegeneration; 1996 Dec; 5(4):473-6. PubMed ID: 9117565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inverse-Warburg effect and the origin of Alzheimer's disease.
    Demetrius LA; Simon DK
    Biogerontology; 2012 Dec; 13(6):583-94. PubMed ID: 23086530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic Alzheimer's disease: the starving brain.
    Mamelak M
    J Alzheimers Dis; 2012; 31(3):459-74. PubMed ID: 22571985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease.
    Rapoport SI
    Neurotox Res; 2003; 5(6):385-98. PubMed ID: 14715441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.